Science & Evidence

Ibogaine Research Database

86 peer-reviewed studies indexed from PubMed. Plain-language summaries where available.

All Studies (86)Opioid Addiction (15)Heroin Addiction (15)PTSD (15)Depression (15)Alcohol Addiction (15)Cocaine Addiction (15)Anxiety (13)Methamphetamine Addiction (12)Traumatic Brain Injury (2)

Studies on Heroin Addiction(11)

← Back to Heroin Addiction

Ibogaine: Revisiting an Ancient Alkaloid for Modern Opioid Dependence.

Moore, Moore, Alzghari· Substance use & misuse· 2026· PMID: 41404929

Ibogaine is a naturally occurring hallucinogenic alkaloid originally used in ritualistic ceremonies by West Central African tribes for centuries. Ibogaine's rise in popularity in the 1960s was fueled by reports from those with a heroin addiction that claimed ibogaine stemmed thei...

The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic,

McAnulty, Bastien, Abboud· Journal of substance use and addiction treatment· 2025· PMID: 40571059

Though opioid agonist therapies are the mainstay of treatment for opioid use disorder, treatment retention remains suboptimal. Improved prediction of who will remain in treatment could lead to improved treatment outcomes. Whether craving predicts reduced retention in treatment re...

Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models.

Havel, Kruegel, Bechand· Nature communications· 2024· PMID: 39304653

Ibogaine and its main metabolite noribogaine provide important molecular prototypes for markedly different treatment of substance use disorders and co-morbid mental health illnesses. However, these compounds present a cardiac safety risk and a highly complex molecular mechanism. ...

Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.

Bozinoff, Tardelli, Rubin-Kahana· Harm reduction journal· 2022· PMID: 36229831

Given the ongoing opioid crisis, novel interventions to treat severe opioid use disorder (OUD) are urgently needed. Injectable opioid agonist therapy (iOAT) with diacetylmorphine or hydromorphone is effective for the treatment of severe, treatment-refractory OUD, however barriers...

Death due to consumption of ibogaine: case report.

Aćimović, Atanasijević, Denić· Forensic science, medicine, and pathology· 2021· PMID: 33433774

Ibogaine is a psychotropic indole alkaloid extracted from the roots of the Tabernanthe iboga shrub from the Apocynaceae family. Depending on the taken dose, it can lead to stimulant effects, euphoria, visual and auditory hallucinations, along with auditory, olfactory, and gustato...

Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias.

Grogan, Gerona, Snow· The Journal of emergency medicine· 2019· PMID: 31630892

Ibogaine is a psychoactive indole alkaloid that has been investigated for use as a treatment for opioid addiction. While not commercially available in the United States, it is available via Internet suppliers. Ibogaine use has been associated with significant cardiac and neurolog...

A case of death due to ibogaine use for heroin addiction: case report.

Jalal, Daher, Hilu· The American journal on addictions· 2013· PMID: 23617876

Complementary medicines in psychiatry: review of effectiveness and safety.

Werneke, Turner, Priebe· The British journal of psychiatry : the journal of mental science· 2006· PMID: 16449696

The use of complementary medicines in those with mental health problems is well documented. However, their effectiveness is often not established and they may be less harmless than commonly assumed. To review the complementary medicines routinely encountered in psychiatric practi...

Ibogaine in the treatment of heroin withdrawal.

Mash, Kovera, Pablo· The Alkaloids. Chemistry and biology· 2001· PMID: 11705106

Ibogaine in acute opioid withdrawal. An open label case series.

Alper, Lotsof, Frenken· Annals of the New York Academy of Sciences· 2000· PMID: 10911935

Treatment of acute opioid withdrawal with ibogaine.

Alper, Lotsof, Frenken· The American journal on addictions· 1999· PMID: 10506904

Ibogaine is an alkaloid with putative effect in acute opioid withdrawal. Thirty-three cases of treatments for the indication of opioid detoxification performed in non-medical settings under open label conditions are summarized involving an average daily use of heroin of .64 +/- ....